Dysregulated D-type cyclins (e.g., CCND1, CCND2, and CCND3) drive the G1-to-S phase cell cycle transition via CDK4/6, contributing to AML pathogenesis (Matsuo et al., 2018; Choi et al., 2012). Here, CCND2 is linked to acute myeloid leukemia.